title: Erythropoietin and ischemic conditioning--why two good things may be bad.
authors.affiliation: Department of Neonatology, Basel University Children's Hospital, Basel, Switzerland. christoph.buehrer@ukbb.ch
authors.forename: Christoph
authors.initials: C
authors.lastname: Bührer
authors.forename: Ursula
authors.initials: U
authors.lastname: Felderhoff-Mueser
authors.forename: Sven
authors.initials: S
authors.lastname: Wellmann
mesh_terms: D000328:Adult; D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology; D001921:Brain / Q000098:blood supply* / Q000378:metabolism; D002423:Cause of Death; D015687:Cell Hypoxia / Q000502:physiology; D004921:Erythropoietin / Q000009:adverse effects* / Q000378:metabolism / Q000502:physiology; D006801:Humans; D002534:Hypoxia, Brain / Q000517:prevention & control*; D007223:Infant; D007231:Infant, Newborn; D019194:Ischemic Preconditioning / Q000379:methods; D051379:Mice; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin